Dr Jo Robson, Associate Professor in Rheumatology, University of the West of England (UWE), and Consultant in Rheumatology, University Hospitals Bristol and Weston NHS Foundation Trust. 

I am the UKIVAS Co-Chair for Rheumatology and co-host of this educational meeting in Bristol. Clinically, I am the clinical lead for Connective Tissue Diseases and Vasculitis at the Bristol Royal Infirmary, University Hospitals Bristol NHS Foundation Trust. We are a specialized center for Rheumatology and host the South West Region Tocilizumab in Giant Cell Arteritis MDT. My research interests include development and validation of patient reported outcomes (AAV PRO, GCA PRO and Steroid PRO), ACR/EULAR classification criteria for systemic vasculitides, impact of rare rheumatic disease on quality of life and intervention design, and outcomes including cardiovascular disease and damage.